Combinent Biomedical Systems
Combinent Biomedical Systems focuses on the transvaginal delivery of drugs targeting women’s reproductive endocrinology disorders.
Launch date
Employees
Market cap
-
Enterprise valuation
€4—5m (Dealroom.co estimates Dec 2010.)
Lexington Kentucky (HQ)
Authorizing premium user...